Here's how LINK.SPRINGER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINK . SPRINGER . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Link.springer.com Make Money
  6. Keywords
  7. Topics
  8. Schema
  9. External Links
  10. Analytics And Tracking
  11. Libraries
  12. CDN Services

We are analyzing https://link.springer.com/article/10.1186/s13046-019-1159-2.

Title:
ALKBH5 inhibited autophagy of epithelial ovarian cancer through miR-7 and BCL-2 | Journal of Experimental & Clinical Cancer Research
Description:
Background ALKBH5 regulated the malignant behavior of breast cancer and glioblastoma. However, the expression and function of ALKBH5 in epithelial ovarian cancer have not yet been determined. In the present study, we investigated the expression and function of ALKBH5 in epithelial ovarian cancer with respect to its potential role in the tumorigenesis of the disease as well as an early diagnostic marker. Methods Immunohistochemistry and western blot were used to detect protein expression. Gene silencing and over-expression experiment were used to study gene function. Cell proliferation assay and Matrigel invasion assays were used to detect cell proliferation and invasion, respectively. The nude mouse tumor formation experiment was used to evaluate the growth of cells in vivo. Results The expression of ALKBH5 was found to be increased in epithelial ovarian cancer tissue as compared to the normal ovarian tissues. The silencing of ALKBH5 in SKOV3 cells enhanced the autophagy and inhibited the proliferation and invasion in vitro and in vivo, whereas the ectopic expression of ALKBH5 in A2780 cells exerted an opposite effect. Mechanical study revealed that ALKBH5 physically interacted with HuR. ALKBH5 activated EGFR-PIK3CA-AKT-mTOR signaling pathway. Also, ALKBH5 enhanced the stability of BCL-2 mRNA and promoted the interaction between Bcl-2 and Beclin1. Conclusion Overall, the present study identified ALKBH5 as a candidate oncogene in epithelial ovarian cancer and a potential target for ovarian cancer therapy.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {πŸ“š}

  • Education
  • Science
  • Health & Fitness

Content Management System {πŸ“}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {πŸ“ˆ}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 7,734,772 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {πŸ’Έ}

We can't figure out the monetization strategy.

Many websites are intended to earn money, but some serve to share ideas or build connections. Websites exist for all kinds of purposes. This might be one of them. Link.springer.com might be cashing in, but we can't detect the method they're using.

Keywords {πŸ”}

alkbh, cells, expression, cancer, autophagy, ovarian, bcl, infected, lvrup, skov, fig, article, mrna, atg, proliferation, beclin, lvrupnc, cell, google, scholar, regulated, inhibited, lvalkbh, study, tumor, hur, ulk, silencing, invasion, increased, lvnc, added, data, egfr, cas, epithelial, concentration, puromycin, mgml, pathway, interaction, rna, lcii, compared, promoted, mtor, protein, ectopic, pikc, luciferase,

Topics {βœ’οΈ}

serine/threonine-protein kinase ulk1 plasmid encoding mrfp-gfp-lc3 monoclonal mouse anti-Ξ²-actin mutant luciferase-bcl-2-3β€²-utr reporter main anti-apoptotic protein bravo-san pedro jm milk-derived fusion peptide ampk/mtor signaling pathway pi3k/akt/mtor pathways therapy-driven anticancer immunosurveillance mrfp-gfp-lc3 reporter luciferase-bcl-2 3β€²-utr reporter pmir-report-bcl-2-3β€²-utr lv3-shalkbh5–1-infected group apoptosis-resistant prostate cancer articleΒ  google scholar article download pdf egfr-pi3k-akt-mtor pathway a2780 cells-infected lv121-alkbh5 mtor-dependent autophagy contributes mrfp-gfp-lc3 distribution lv3-nc-infected group alkbh5-mediated m6a-demethylation alkbh5-lentiviral expression vector lvru6p-nc-infected skov3 cells mtor signaling pathway full access lv121-alkbh5-infected group alkbh5 silencing-induced autophagy protein kinase mtor privacy choices/manage cookies irrelevant primary antibodies lv121-nc-infected group luciferase reporter assay long 3β€²-utr mrnas phenol/chloroform extraction mrfp-gfp-lc3 flavopiridol-treated cells relative lvru6p-nc-infected group alkbh5-mediated bcl-2 regulation serous ovarian carcinoma alternative splicing events creative commons license ovarian cancer therapy epithelial ovarian cancer ovarian cancer tissue potential clinical significance b-cell lymphoma-2 common rna modifications lvru6p-02-infected skov3 cells

Schema {πŸ—ΊοΈ}

WebPage:
      mainEntity:
         headline:ALKBH5 inhibited autophagy of epithelial ovarian cancer through miR-7 and BCL-2
         description:ALKBH5 regulated the malignant behavior of breast cancer and glioblastoma. However, the expression and function of ALKBH5 in epithelial ovarian cancer have not yet been determined. In the present study, we investigated the expression and function of ALKBH5 in epithelial ovarian cancer with respect to its potential role in the tumorigenesis of the disease as well as an early diagnostic marker. Immunohistochemistry and western blot were used to detect protein expression. Gene silencing and over-expression experiment were used to study gene function. Cell proliferation assay and Matrigel invasion assays were used to detect cell proliferation and invasion, respectively. The nude mouse tumor formation experiment was used to evaluate the growth of cells in vivo. The expression of ALKBH5 was found to be increased in epithelial ovarian cancer tissue as compared to the normal ovarian tissues. The silencing of ALKBH5 in SKOV3 cells enhanced the autophagy and inhibited the proliferation and invasion in vitro and in vivo, whereas the ectopic expression of ALKBH5 in A2780 cells exerted an opposite effect. Mechanical study revealed that ALKBH5 physically interacted with HuR. ALKBH5 activated EGFR-PIK3CA-AKT-mTOR signaling pathway. Also, ALKBH5 enhanced the stability of BCL-2 mRNA and promoted the interaction between Bcl-2 and Beclin1. Overall, the present study identified ALKBH5 as a candidate oncogene in epithelial ovarian cancer and a potential target for ovarian cancer therapy.
         datePublished:2019-04-15T00:00:00Z
         dateModified:2019-04-15T00:00:00Z
         pageStart:1
         pageEnd:15
         license:http://creativecommons.org/publicdomain/zero/1.0/
         sameAs:https://doi.org/10.1186/s13046-019-1159-2
         keywords:
            ALKBH5
            BCL-2
            Beclin1
            Autophagy
            miR-7, EGFR
            Cancer Research
            Immunology
            Apoptosis
            Oncology
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13046-019-1159-2/MediaObjects/13046_2019_1159_Fig1_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13046-019-1159-2/MediaObjects/13046_2019_1159_Fig2_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13046-019-1159-2/MediaObjects/13046_2019_1159_Fig3_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13046-019-1159-2/MediaObjects/13046_2019_1159_Fig4_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13046-019-1159-2/MediaObjects/13046_2019_1159_Fig5_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13046-019-1159-2/MediaObjects/13046_2019_1159_Fig6_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13046-019-1159-2/MediaObjects/13046_2019_1159_Fig7_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13046-019-1159-2/MediaObjects/13046_2019_1159_Fig8_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13046-019-1159-2/MediaObjects/13046_2019_1159_Fig9_HTML.png
         isPartOf:
            name:Journal of Experimental & Clinical Cancer Research
            issn:
               1756-9966
            volumeNumber:38
            type:
               Periodical
               PublicationVolume
         publisher:
            name:BioMed Central
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Hongtao Zhu
               affiliation:
                     name:Second Affiliated Hospital, Chongqing Medical University
                     address:
                        name:Department of Obstetrics and Gynecology, Second Affiliated Hospital, Chongqing Medical University, Chongqing, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Xiaoling Gan
               affiliation:
                     name:Second Affiliated Hospital, Chongqing Medical University
                     address:
                        name:Department of Obstetrics and Gynecology, Second Affiliated Hospital, Chongqing Medical University, Chongqing, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Xingwei Jiang
               affiliation:
                     name:Second Affiliated Hospital, Chongqing Medical University
                     address:
                        name:Department of Obstetrics and Gynecology, Second Affiliated Hospital, Chongqing Medical University, Chongqing, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Shuai Diao
               affiliation:
                     name:Second Affiliated Hospital, Chongqing Medical University
                     address:
                        name:Department of Obstetrics and Gynecology, Second Affiliated Hospital, Chongqing Medical University, Chongqing, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Huan Wu
               affiliation:
                     name:Second Affiliated Hospital, Chongqing Medical University
                     address:
                        name:Department of Obstetrics and Gynecology, Second Affiliated Hospital, Chongqing Medical University, Chongqing, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Jianguo Hu
               affiliation:
                     name:Second Affiliated Hospital, Chongqing Medical University
                     address:
                        name:Department of Obstetrics and Gynecology, Second Affiliated Hospital, Chongqing Medical University, Chongqing, China
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:ALKBH5 inhibited autophagy of epithelial ovarian cancer through miR-7 and BCL-2
      description:ALKBH5 regulated the malignant behavior of breast cancer and glioblastoma. However, the expression and function of ALKBH5 in epithelial ovarian cancer have not yet been determined. In the present study, we investigated the expression and function of ALKBH5 in epithelial ovarian cancer with respect to its potential role in the tumorigenesis of the disease as well as an early diagnostic marker. Immunohistochemistry and western blot were used to detect protein expression. Gene silencing and over-expression experiment were used to study gene function. Cell proliferation assay and Matrigel invasion assays were used to detect cell proliferation and invasion, respectively. The nude mouse tumor formation experiment was used to evaluate the growth of cells in vivo. The expression of ALKBH5 was found to be increased in epithelial ovarian cancer tissue as compared to the normal ovarian tissues. The silencing of ALKBH5 in SKOV3 cells enhanced the autophagy and inhibited the proliferation and invasion in vitro and in vivo, whereas the ectopic expression of ALKBH5 in A2780 cells exerted an opposite effect. Mechanical study revealed that ALKBH5 physically interacted with HuR. ALKBH5 activated EGFR-PIK3CA-AKT-mTOR signaling pathway. Also, ALKBH5 enhanced the stability of BCL-2 mRNA and promoted the interaction between Bcl-2 and Beclin1. Overall, the present study identified ALKBH5 as a candidate oncogene in epithelial ovarian cancer and a potential target for ovarian cancer therapy.
      datePublished:2019-04-15T00:00:00Z
      dateModified:2019-04-15T00:00:00Z
      pageStart:1
      pageEnd:15
      license:http://creativecommons.org/publicdomain/zero/1.0/
      sameAs:https://doi.org/10.1186/s13046-019-1159-2
      keywords:
         ALKBH5
         BCL-2
         Beclin1
         Autophagy
         miR-7, EGFR
         Cancer Research
         Immunology
         Apoptosis
         Oncology
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13046-019-1159-2/MediaObjects/13046_2019_1159_Fig1_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13046-019-1159-2/MediaObjects/13046_2019_1159_Fig2_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13046-019-1159-2/MediaObjects/13046_2019_1159_Fig3_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13046-019-1159-2/MediaObjects/13046_2019_1159_Fig4_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13046-019-1159-2/MediaObjects/13046_2019_1159_Fig5_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13046-019-1159-2/MediaObjects/13046_2019_1159_Fig6_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13046-019-1159-2/MediaObjects/13046_2019_1159_Fig7_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13046-019-1159-2/MediaObjects/13046_2019_1159_Fig8_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13046-019-1159-2/MediaObjects/13046_2019_1159_Fig9_HTML.png
      isPartOf:
         name:Journal of Experimental & Clinical Cancer Research
         issn:
            1756-9966
         volumeNumber:38
         type:
            Periodical
            PublicationVolume
      publisher:
         name:BioMed Central
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Hongtao Zhu
            affiliation:
                  name:Second Affiliated Hospital, Chongqing Medical University
                  address:
                     name:Department of Obstetrics and Gynecology, Second Affiliated Hospital, Chongqing Medical University, Chongqing, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Xiaoling Gan
            affiliation:
                  name:Second Affiliated Hospital, Chongqing Medical University
                  address:
                     name:Department of Obstetrics and Gynecology, Second Affiliated Hospital, Chongqing Medical University, Chongqing, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Xingwei Jiang
            affiliation:
                  name:Second Affiliated Hospital, Chongqing Medical University
                  address:
                     name:Department of Obstetrics and Gynecology, Second Affiliated Hospital, Chongqing Medical University, Chongqing, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Shuai Diao
            affiliation:
                  name:Second Affiliated Hospital, Chongqing Medical University
                  address:
                     name:Department of Obstetrics and Gynecology, Second Affiliated Hospital, Chongqing Medical University, Chongqing, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Huan Wu
            affiliation:
                  name:Second Affiliated Hospital, Chongqing Medical University
                  address:
                     name:Department of Obstetrics and Gynecology, Second Affiliated Hospital, Chongqing Medical University, Chongqing, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Jianguo Hu
            affiliation:
                  name:Second Affiliated Hospital, Chongqing Medical University
                  address:
                     name:Department of Obstetrics and Gynecology, Second Affiliated Hospital, Chongqing Medical University, Chongqing, China
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:Journal of Experimental & Clinical Cancer Research
      issn:
         1756-9966
      volumeNumber:38
Organization:
      name:BioMed Central
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Second Affiliated Hospital, Chongqing Medical University
      address:
         name:Department of Obstetrics and Gynecology, Second Affiliated Hospital, Chongqing Medical University, Chongqing, China
         type:PostalAddress
      name:Second Affiliated Hospital, Chongqing Medical University
      address:
         name:Department of Obstetrics and Gynecology, Second Affiliated Hospital, Chongqing Medical University, Chongqing, China
         type:PostalAddress
      name:Second Affiliated Hospital, Chongqing Medical University
      address:
         name:Department of Obstetrics and Gynecology, Second Affiliated Hospital, Chongqing Medical University, Chongqing, China
         type:PostalAddress
      name:Second Affiliated Hospital, Chongqing Medical University
      address:
         name:Department of Obstetrics and Gynecology, Second Affiliated Hospital, Chongqing Medical University, Chongqing, China
         type:PostalAddress
      name:Second Affiliated Hospital, Chongqing Medical University
      address:
         name:Department of Obstetrics and Gynecology, Second Affiliated Hospital, Chongqing Medical University, Chongqing, China
         type:PostalAddress
      name:Second Affiliated Hospital, Chongqing Medical University
      address:
         name:Department of Obstetrics and Gynecology, Second Affiliated Hospital, Chongqing Medical University, Chongqing, China
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Hongtao Zhu
      affiliation:
            name:Second Affiliated Hospital, Chongqing Medical University
            address:
               name:Department of Obstetrics and Gynecology, Second Affiliated Hospital, Chongqing Medical University, Chongqing, China
               type:PostalAddress
            type:Organization
      name:Xiaoling Gan
      affiliation:
            name:Second Affiliated Hospital, Chongqing Medical University
            address:
               name:Department of Obstetrics and Gynecology, Second Affiliated Hospital, Chongqing Medical University, Chongqing, China
               type:PostalAddress
            type:Organization
      name:Xingwei Jiang
      affiliation:
            name:Second Affiliated Hospital, Chongqing Medical University
            address:
               name:Department of Obstetrics and Gynecology, Second Affiliated Hospital, Chongqing Medical University, Chongqing, China
               type:PostalAddress
            type:Organization
      name:Shuai Diao
      affiliation:
            name:Second Affiliated Hospital, Chongqing Medical University
            address:
               name:Department of Obstetrics and Gynecology, Second Affiliated Hospital, Chongqing Medical University, Chongqing, China
               type:PostalAddress
            type:Organization
      name:Huan Wu
      affiliation:
            name:Second Affiliated Hospital, Chongqing Medical University
            address:
               name:Department of Obstetrics and Gynecology, Second Affiliated Hospital, Chongqing Medical University, Chongqing, China
               type:PostalAddress
            type:Organization
      name:Jianguo Hu
      affiliation:
            name:Second Affiliated Hospital, Chongqing Medical University
            address:
               name:Department of Obstetrics and Gynecology, Second Affiliated Hospital, Chongqing Medical University, Chongqing, China
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Department of Obstetrics and Gynecology, Second Affiliated Hospital, Chongqing Medical University, Chongqing, China
      name:Department of Obstetrics and Gynecology, Second Affiliated Hospital, Chongqing Medical University, Chongqing, China
      name:Department of Obstetrics and Gynecology, Second Affiliated Hospital, Chongqing Medical University, Chongqing, China
      name:Department of Obstetrics and Gynecology, Second Affiliated Hospital, Chongqing Medical University, Chongqing, China
      name:Department of Obstetrics and Gynecology, Second Affiliated Hospital, Chongqing Medical University, Chongqing, China
      name:Department of Obstetrics and Gynecology, Second Affiliated Hospital, Chongqing Medical University, Chongqing, China

External Links {πŸ”—}(94)

Analytics and Tracking {πŸ“Š}

  • Google Tag Manager

Libraries {πŸ“š}

  • Clipboard.js
  • Prism.js

CDN Services {πŸ“¦}

  • Crossref

5.74s.